ISSN 2630-5593

Quick Search




The Anatolian Journal of Family Medicine GUT MICROBIATA: FROM THE PERSPECTIVE OF CARDIOMETABOLIC DISEASES [anatol j fm]
anatol j fm. 2018; 1(1): 2-7 | DOI: 10.5505/anatoljfm.2018.10820

GUT MICROBIATA: FROM THE PERSPECTIVE OF CARDIOMETABOLIC DISEASES

İsmet Tamer
Kartal Dr Lutfi Kirdar Training and Research Hospital, Department of Family Medicine, Kartal, Istanbul, Turkey

Considering the prevalence of obesity, diabetes and cardiovascular diseases, significant interest has been focused on the gut microbiota-diabetes and cardiovascular system interaction, because the gut microbiota has been recognized as a modulator of human health. Dysbiosis, characterized by pathological changes in the gut microbiota, has been reported in cardimetabolic disorders, such as overweight and obesity, dyslipidaemia, atherosclerosis and hypertension. Furthermore, dysbiosis can disturb gut immunity, which increases the risk of acute cardiometabolic events. Therefore, the changes in the composition of the gut microbiota can affect host metabolism and immunity. The aim of this review is to look through the current knowledge over gut microbiata and expand the view on key roles of intestinal microflora during development of cardiometabolic diseases as T2DM, hypertension, dyslipidemia and atherosclerosis, also discuss the roles of microbiata regulating agents such as pre- and probiotics.

Keywords: Microbiata, obesity, diabetes, metabolic disease, cardiovascular

İsmet Tamer. GUT MICROBIATA: FROM THE PERSPECTIVE OF CARDIOMETABOLIC DISEASES. anatol j fm. 2018; 1(1): 2-7

Corresponding Author: İsmet Tamer, Türkiye
LookUs & Online Makale